Recruiting

AR/VR Application for Pain Relief in Renal Colic Patients

What is being tested

Commercial AR/VR Headset with Calming App

+ Pharmacologic Standard of Care Alone

DeviceOther

Who is being recruted

Urogenital Diseases+21

+ Agnosia

+ Calculi

Over 18 Years

+20 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Interventional

Study Start: April 2025

See protocol details

Summary

Principal SponsorCommunity Medical Center, Toms River, NJ

Study ContactGreg Neyman, MD

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 2025

Actual date on which the first participant was enrolled.

This study focuses on patients who visit the emergency department (ED) with symptoms of renal colic, a severe type of pain caused by kidney stones. The aim is to explore whether using a virtual or augmented reality (VR/AR) calming application, in addition to the usual pain medications, can help reduce the discomfort experienced by these patients. Kidney stones can be extremely painful, and finding new ways to alleviate this pain could significantly improve patient care and comfort. Participants in this study are divided into two groups. One group receives the standard pain relief medication typically used for kidney stones. The other group receives the same medication along with a calming VR/AR experience using a headset. The study evaluates whether the additional use of VR/AR technology helps in managing pain more effectively than medication alone. There are no specific risks mentioned, but the potential benefit is a more comfortable experience for patients during their ED visit.

Official TitleThe Use of AR / VR in Patients Presenting to the ED With Renal Colic

NCT07070401

Principal SponsorCommunity Medical Center, Toms River, NJ

Study ContactGreg Neyman, MD

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

92 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesAgnosiaCalculiEmergenciesFemale Urogenital Diseases and Pregnancy ComplicationsKidney CalculiKidney DiseasesNervous System DiseasesNeurologic ManifestationsPainPathologic ProcessesPerceptual DisordersSigns and SymptomsPathological Conditions, Signs and SymptomsUrinary CalculiUrologic DiseasesNeurobehavioral ManifestationsPathological Conditions, AnatomicalDisease AttributesFemale Urogenital DiseasesMale Urogenital DiseasesUrolithiasisNephrolithiasisRenal Colic

Criteria

9 inclusion criteria required to participate

Patient self-reported history of nephrolithiasis

Subjective history suggesting that current presentation is similar to past presentations of nephrolithiasis (character, quality, location, intensity of pain; previous surgical intervention or lithotripsy)

Patients with self-reported moderate to severe pain on the visual pain scale determined as greater than 5/10

Normal vital signs (afebrile)

Show More Criteria

11 exclusion criteria prevent from participating

Age < 18 years

Pregnant

Individuals with chronic pain conditions such as fibromyalgia (chronic pain may confound results, as patients may have higher than baseline pain levels affecting their response to medications)

Individuals with severe anxiety or claustrophobia

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group

Treatment Groups

Group I

Experimental

Patients receive adjunct AR Calming App via commercial AR/VR headset in addition to standard of care pharmacologic management at the discretion of the treating provider

Group II

Active Comparator

Patients receive standard of care pharmacologic management at the discretion of the treating provider

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Rutgers Robert Wood Johnson Barnabas Health Community Medical Center

Toms River, United StatesOpen Rutgers Robert Wood Johnson Barnabas Health Community Medical Center in Google Maps

Recruiting

One Study Center